Intragraft Toll-like receptor profiling in acute renal allograft rejection

Nephrology Dialysis Transplantation

Volumn 25, Issue 12, 2010, Pages 4087-4092

  Dessing, Mark C ^a   Bemelman, Frederike J ^a   Claessen, Nike ^a   Ten Berge, Ineke J M ^a   Florquin, Sandrine ^a   Leemans, Jaklien C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

allograft rejection; kidney; Toll like receptors; transplantation

Indexed keywords

BASILIXIMAB; CD14 ANTIGEN; CYCLOSPORIN A; INTERLEUKIN 1 RECEPTOR; MESSENGER RNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD14; BIOPSY; CHILD; FEMALE; GENE EXPRESSION PROFILING; GRAFT REJECTION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; KIDNEY TRANSPLANTATION; LYMPHOCYTE ANTIGEN 96; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-1; TOLL-LIKE RECEPTORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 78649521641     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq589     Document Type: Article

References (26)

1. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675-680 (Pubitemid 32747155)
2. Akobeng AK. Understanding diagnostic tests 2: likelihood ratios, pre- and post-test probabilities and their use in clinical practice. Acta Paediatr 2007; 96: 487-491
3. Alegre ML, Goldstein DR, Chong AS. Toll-like receptor signaling in transplantation. Curr Opin Organ Transplant 2008; 13: 358-365
4. Alegre ML, Leemans J, Le Moine A et al. The multiple facets of tolllike receptorsin transplantation biology. Transplantation 2008; 86: 1-9
5. Alexopoulou L, Holt AC, Medzhitov R et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001; 413: 732-738
6. Bohmig GA, Exner M, Habicht A et al. Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 2002; 13: 1091-1099
7. Braudeau C, Ashton-Chess J, Giral M et al. Contrasted blood and in-tragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients. Transplantation 2008; 86: 130-136
8. Cavassani KA, Ishii M, Wen H et al. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med 2008; 205: 2609-2621
9. De Groot K, Kuklik K, Brocker Vet al. Toll-like receptor 2 and renal allograft function. Am J Nephrol 2008; 28: 583-588
10. Gluba A, Banach M, Hannam S et al. The role of Toll-like receptors in renal diseases. Nat Rev Nephrol 2010; 6: 224-235
11. Jaresova I, Rozkova D, Spisek R et al. Kinetics of Toll-like receptor-4 splice variants expression in lipopolysaccharide-stimulated antigen presenting cells of healthy donors and patients with cystic fibrosis. Microbes Infect 2007; 9: 1359-1367
12. Johnson GB, Brunn GJ, Platt JL. Activation of mammalian Toll-like receptors by endogenous agonists. Crit Rev Immunol 2003; 23: 15-44
13. Kwon J, Park J, Lee D et al. Toll-like receptor expression in patients with renal allograft dysfunction. Transplant Proc 2008; 40: 3479-3480
14. Magee CC, Pascual M. Update in renal transplantation. Arch Intern Med 2004; 164: 1373-1388
15. Maris NA, Dessing MC, de Vos AF et al. Toll-like receptor mRNA levels in alveolar macrophages after inhalation of endotoxin. Eur Respir J 2006; 28: 622-626
16. Nishimura M, Naito S. Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biol Pharm Bull 2005; 28: 886-892
17. Nishitani C, Mitsuzawa H, Sano H et al. Toll-like receptor 4 region Glu24-Lys47 is a site for MD-2 binding: importance of CYS29 and CYS40. J Biol Chem 2006; 281: 38322-38329
18. Pina TC, Zapata IT, Lopez JB et al. Tumor markers in lung cancer: does the method of obtaining the cut-off point and reference population influence diagnostic yield? Clin Biochem 1999; 32: 467-472
19. Polentarutti N, Rol GP, Muzio M et al. Unique pattern of expression and inhibition of IL-1 signaling by the IL-1 receptor family member TIR8/SIGIRR. Eur Cytokine Netw 2003; 14: 211-218
20. Scheepstra C, Bemelman FJ, Van der Loos C et al. B cells in cluster or in a scattered pattern do not correlate with clinical outcome of renal allograft rejection. Transplantation 2008; 86: 772-778
21. Shirali AC, Goldstein DR. Tracking the toll of kidney disease. J Am Soc Nephrol 2008; 19: 1444-1450
22. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753-760 (Pubitemid 351347767)
23. Sutmuller RP, Morgan ME, Netea MG et al. Toll-like receptors on regulatory T cells: expanding immune regulation. Trends Immunol 2006; 27: 387-393
24. Tsuboi N, Yoshikai Y, Matsuo S et al. Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 2002; 169: 2026-2033
25. Wald D, Qin J, Zhao Z et al. SIGIRR, a negative regulator of Tolllike receptor-interleukin 1 receptor signaling. Nat Immunol 2003; 4: 920-927
26. Yapici U, Bemelman FJ, Scheepstra CG et al. Intragraft FOXP3 protein or mRNA during acute renal allograft rejection correlates with inflammation, fibrosis, and poor renal outcome. Transplantation 2009; 87: 1377-1380